U.S. Electronic Equipment and Components Stock News

NYSE:OTIS
NYSE:OTISMachinery

Is It Time To Reconsider Otis Worldwide (OTIS) After A 20% One Year Share Price Slide?

If you have been wondering whether Otis Worldwide stock is attractively priced or just fairly valued at around US$76.71, the key is to look closely at what the current valuation actually reflects. Over the last week the stock is roughly flat with a 0.1% return, while the 30 day return of a 1.8% decline and the 1 year return of a 19.7% decline hint that sentiment around the long term story has shifted. Recent coverage has focused on how elevator and escalator demand ties into broader...
NYSE:CBL
NYSE:CBLRetail REITs

CBL & Associates Properties (CBL) Valuation After Fayette Mall Refinancing And Higher Expected Cash Flow

CBL & Associates Properties (CBL) has completed refinancing for Fayette Mall in Lexington, Kentucky, replacing a $98.6 million loan with a $97.5 million five-year non-recourse CMBS facility at an approximate 7.25% fixed rate. See our latest analysis for CBL & Associates Properties. The refinancing news lands after a strong run in the stock, with a 30 day share price return of 7.63%, a 90 day gain of 21.73% and a 1 year total shareholder return of 92.43%, suggesting momentum has been building...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Surging Q1 Revenue And Narrower Losses Might Change The Case For Investing In Wave (WVE)

Wave Life Sciences Ltd. recently reported first-quarter 2026 results, with sales rising to US$38.25 million from US$9.18 million a year earlier and net loss narrowing to US$26.09 million. This combination of stronger revenue and a smaller loss per share suggests the company’s operations may be scaling more efficiently than in the prior-year period. With revenue more than quadrupling year over year, we’ll now examine how this improved financial performance influences Wave Life Sciences’...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

Is DoorDash (DASH) Still Attractive After Mixed Returns And Rich P/E Multiple

If you are wondering whether DoorDash at around US$167.97 still represents good value or growing risk, the answer depends on which valuation lens you use and how you think its story plays out from here. The stock has seen mixed returns, with a 0.8% decline over the last week, an 8.3% gain over the last month, a 23.6% decline year to date, and a 5.1% decline over the last year, while still sitting on a very large 3 year return of 144.3% and a 5 year return of 48.7%. Recent coverage has...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Is It Too Late To Consider ON Semiconductor (ON) After Its 172% One Year Surge

Wondering if ON Semiconductor at around US$105.77 is still offering value, or if the easy money has already been made. The stock has returned 7.0% over the last week, 66.6% over the last month, 86.5% year to date and 172.6% over the past year, with longer term 3 year and 5 year returns of 32.4% and 196.5%. Recent price action has kept ON Semiconductor in focus as investors weigh how current expectations line up with the company’s positioning in the semiconductor sector. Broader interest in...
NYSE:NU
NYSE:NUBanks

Assessing Nu Holdings (NYSE:NU) Valuation After Mixed Recent Share Performance

Understanding Nu Holdings after recent share performance Nu Holdings (NYSE:NU) has drawn fresh attention after recent share performance that includes a month gain of 1.5% alongside a negative move of 13.9% over the past 3 months, prompting investors to reassess the stock. See our latest analysis for Nu Holdings. At a share price of $14.48, Nu Holdings has seen short term share price momentum fade, with a 7 day share price return of 3.13% set against a 3 month share price decline of 13.86%,...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

The Bull Case For Incyte (INCY) Could Change Following FDA Approval Of Once-Daily Jakafi XR

In early May 2026, Incyte received U.S. FDA approval for Jakafi XR, a once-daily extended-release ruxolitinib tablet for multiple hematologic and graft-versus-host disease indications, after bioequivalence and safety were established against the existing twice-daily formulation. This approval, alongside materially higher first-quarter 2026 revenue of US$1.27 billion and net income of US$303.33 million versus a year earlier, underscores how incremental product enhancements and portfolio...
NasdaqGS:STX
NasdaqGS:STXTech

Is It Too Late To Consider Seagate Technology Holdings (STX) After Its Recent 7x Surge?

Wondering whether Seagate Technology Holdings at around US$786 a share still makes sense on a value basis? This article breaks down what that price could mean for you. The stock has posted very strong recent returns, including 22.2% over 7 days, 73.5% over 30 days and 173.5% year to date, with a 1 year gain of roughly 7x and very large 3 and 5 year returns. Recent coverage has focused on Seagate's role in data storage hardware and its exposure to trends such as cloud computing and data...
NYSE:TGLS
NYSE:TGLSBuilding

Undervalued Small Caps With Insider Buying Opportunities In May 2026

The United States market has shown robust performance recently, with a 3.2% increase over the last week and a remarkable 31% rise over the past year, while earnings are expected to grow by 16% annually. In this thriving environment, identifying small-cap stocks that may be undervalued and exhibit insider buying can present unique opportunities for investors seeking potential growth in their portfolios.
NasdaqCM:CXDO
NasdaqCM:CXDOIT

High Growth Tech Stocks to Watch in the US May 2026

The United States market has shown a robust performance, climbing 3.2% in the last week and up 31% over the past year, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.
NYSE:WAT
NYSE:WATLife Sciences

Identifying May 2026 Stocks Trading Below Estimated Value

The United States market has shown robust growth, with a 3.2% increase over the past week and a remarkable 31% rise over the last year, while earnings are anticipated to grow by 16% annually. In this environment, identifying stocks that are trading below their estimated value can offer investors potential opportunities for gains amidst overall market optimism.
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

May 2026's Top Insider Picks For Growth Companies

The United States market has recently experienced a notable upswing, climbing 3.2% in the last week and an impressive 31% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership are particularly attractive as they often indicate strong confidence from those closest to the business, aligning well with current market momentum.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

May 2026's Standout Penny Stocks To Watch

The market has climbed 3.2% in the last 7 days and is up 31% over the last 12 months, with earnings forecast to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks — despite their somewhat outdated name — can still offer surprising value. In this article, we highlight several penny stocks that demonstrate financial strength and have the potential for long-term growth.